A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma.
Clinical trial NCT01237236 · COMPLETED
Trial details
- NCT number
- NCT01237236
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-21
- Primary completion
- 2017-03-09
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.